Journal: bioRxiv
Article Title: Fibroblasts regulate lymphatic barrier functions in a tissue dependent manner
doi: 10.1101/2025.04.17.649442
Figure Lengend Snippet: (A) Schematic diagram of transwell secretome experiment. ( B) TEER measurements of hLEC monolayers after 48 hours of treatment with dermal fibroblast secretomes with [NHDF(G)] and without growth factors [NHDF(B)]. ( C) Representative immunofluorescence images of VE-cadherin, claudin-5, and ZO-1 on hLECs following treatment with NHDF secretomes. (D) Quantification of VE-cadherin, claudin-5, and ZO-1 expression levels using ImageJ (FIJI). (E) Quantification of lymphatic markers LYVE-1 and PROX1 expression in hLEC monolayers treated with NHDF secretomes. (F) FITC–Dextran (4 kDa) transport assay across hLECs after NHDF secretome treatment. Data are presented as mean ± SEM from n = 6 independent experiments. Statistical analysis was performed using an unpaired two-tailed t -test; p > 0.05 = not significant (ns), p ≤ 0.0001 = extremely significant (****). For the permeability (transport) assay ( n = 3, representative), statistical significance was determined by two-way ANOVA followed by appropriate post hoc test for multiple comparisons.
Article Snippet: Normal human primary dermal fibroblasts (NHDF) were cultured in two conditions: (1) NHDF(G) (PromoCell, C-12302) in Fibroblast Growth Medium-2 (PromoCell, C-23120) containing 2% FBS, 1 ng/mL fibroblast growth factor, and 5 μg/mL insulin, or (2) NHDF(B) in fibroblast basal medium without supplements.
Techniques: Immunofluorescence, Expressing, Transport Assay, Two Tailed Test, Permeability